Cargando…
Development of a Stability-Indicating Analytical Method for Determination of Venetoclax Using AQbD Principles
[Image: see text] Venetoclax is an emerging drug for the treatment of various types of blood cancers. It was first approved in 2016 for the treatment of relapsed and refractory chronic lymphocytic leukemia. Later, the indications expanded, and multiple research as well as clinical studies are still...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2020
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377371/ https://www.ncbi.nlm.nih.gov/pubmed/32715260 http://dx.doi.org/10.1021/acsomega.0c02338 |